DocJohn
09-29-2006, 08:30 PM
(From Yahoo) Reuters - Johnson & Johnson on Friday said U.S. health regulators would not approve the company's next-generation schizophrenia drug, paliperidone extended-release, until certain conditions are met.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/nm/20060929/hl_nm/jandj_schizophrenia_dc)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/nm/20060929/hl_nm/jandj_schizophrenia_dc)